Why can't we use bug bounties for pharmaceuticals company?

Question

Do you think it could be possible create a bug bounty program for illnesses. For example the WHO offers 10B USD for a medicine that can cure HIV (could be more or less). But once the price has been paid the molecule or the medicine is available to all manufacturers.I think this could solve issues like having a medicine available only to rich countries.

PaulHoule · Accepted Answer

Coming up with a candidate molecule is the easy part. It has a 1 in 1000 chance of running the gauntlet to the point where you would do human testing. You will have to give the drug to 1000s of people and monitor their condition. Then you will have to figure out how to manufacture the molecule at scale.
The status quo is a remarkably good match to the requirements of drug development.
You have to not only pay for the blockbuster drug but you have to pay for all the failures.

robthebrew · Answer

Well, a computer bug is easy to verify. It is typically: your thing is broken and here I show that it is broken. A pharma "bug bounty" requires a whole heck of a lot of testing. It is a different question and answer: We do not have this, can someone make it? Sure, I made it: but did you test it on humans? Were there side effects? etc. bug bounties are like crypto mining in the sense that you don't do anything except find faults. Pharma discovery is all about discovery.

cinntaile · Answer

Assuming there is a megafund that pays for the development. Why would a for profit pharma company do this? There is no profit to be made once the development is done?

warrenm · Answer

I think you don't understand how remarkably difficult it is to not only find a new drug/treatment, but also to then prove it's "safe" [enough] to market20 years ago, the average cost of developing ONE new drug (counting failed attempts along the way, testing, certification, etc etc) was north of $1 billion USI guarantee it hasn't gotten cheaper in the meantime

neximo64 · Answer

I think you overestimate the amount that can be raised, i.e $10bn. It is really hard to raise those type of amounts, even with crowdfunding, without rich countries. Especially when the cash ends up sitting there.If it was committed but you could use it until the bounty was met then that's different. But then you end up back at the old pricing model.